DK888D0 - PRACTICALLY TAKEN PURE HUMANT PROTEIN LYMPHOKIN AND ITS USE - Google Patents

PRACTICALLY TAKEN PURE HUMANT PROTEIN LYMPHOKIN AND ITS USE

Info

Publication number
DK888D0
DK888D0 DK000888A DK888A DK888D0 DK 888 D0 DK888 D0 DK 888D0 DK 000888 A DK000888 A DK 000888A DK 888 A DK888 A DK 888A DK 888 D0 DK888 D0 DK 888D0
Authority
DK
Denmark
Prior art keywords
lymphokin
humant
protein
practically taken
taken pure
Prior art date
Application number
DK000888A
Other languages
Danish (da)
Other versions
DK888A (en
Inventor
Richard Kornbluth
Thomas S Edgington
Susan A Gregory
Original Assignee
Scripps Clinic Res
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Scripps Clinic Res filed Critical Scripps Clinic Res
Publication of DK888D0 publication Critical patent/DK888D0/en
Publication of DK888A publication Critical patent/DK888A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/8215—Microorganisms
    • Y10S435/948—Microorganisms using viruses or cell lines
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/827—Proteins from mammals or birds

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DK000888A 1986-05-05 1988-01-04 PRACTICALLY TAKEN PURE HUMANT PROTEIN LYMPHOKIN AND ITS USE DK888A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US06/859,604 US4785077A (en) 1986-05-05 1986-05-05 Substantially pure cytotoxicity triggering factor
PCT/US1987/001078 WO1987006942A1 (en) 1986-05-05 1987-05-04 Substantially pure cytotoxicity triggering factor

Publications (2)

Publication Number Publication Date
DK888D0 true DK888D0 (en) 1988-01-04
DK888A DK888A (en) 1988-03-01

Family

ID=25331313

Family Applications (1)

Application Number Title Priority Date Filing Date
DK000888A DK888A (en) 1986-05-05 1988-01-04 PRACTICALLY TAKEN PURE HUMANT PROTEIN LYMPHOKIN AND ITS USE

Country Status (8)

Country Link
US (1) US4785077A (en)
EP (1) EP0265516A1 (en)
JP (1) JPH01500591A (en)
AU (1) AU7434987A (en)
DK (1) DK888A (en)
FI (1) FI880020A (en)
WO (1) WO1987006942A1 (en)
ZA (1) ZA873212B (en)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4920196A (en) * 1982-07-30 1990-04-24 Genentech, Inc. Human lymphotoxin
US4849506A (en) * 1984-04-13 1989-07-18 Akzo N.V. Leukoregulin, an antitumor lymphokine, and its therapeutic uses
JPS63126897A (en) * 1986-05-02 1988-05-30 Yoshitomi Pharmaceut Ind Ltd Immunosuppressive factor
US4844893A (en) * 1986-10-07 1989-07-04 Scripps Clinic And Research Foundation EX vivo effector cell activation for target cell killing
US5112948A (en) * 1986-10-10 1992-05-12 Jones C Michael Methods and compositions for inducing monocyte cytotoxicity
US5434247A (en) * 1986-10-10 1995-07-18 Board Of Regents, The University Of Texas System Peptides for inducing monocyte cytotoxicity in diagnostics
JP2926409B2 (en) * 1989-05-22 1999-07-28 株式会社林原生物化学研究所 Method for producing cancer metastasis inhibitor
WO1991010377A1 (en) 1990-01-10 1991-07-25 Ellis Frampton E Iii Shoe sole structures
US6749853B1 (en) * 1992-03-05 2004-06-15 Board Of Regents, The University Of Texas System Combined methods and compositions for coagulation and tumor treatment
US6004555A (en) * 1992-03-05 1999-12-21 Board Of Regents, The University Of Texas System Methods for the specific coagulation of vasculature
US6093399A (en) * 1992-03-05 2000-07-25 Board Of Regents, The University Of Texas System Methods and compositions for the specific coagulation of vasculature
US6036955A (en) * 1992-03-05 2000-03-14 The Scripps Research Institute Kits and methods for the specific coagulation of vasculature
US5877289A (en) * 1992-03-05 1999-03-02 The Scripps Research Institute Tissue factor compositions and ligands for the specific coagulation of vasculature
US5641867A (en) * 1993-09-29 1997-06-24 The Trustees Of Columbia University In The City Of New York Antibody which specifically binds to endothelial-monocyte activating polypeptide II
US5667964A (en) * 1994-10-28 1997-09-16 Cornell Research Foundation, Inc. Rapid, direct, and qualitative method for the determination of the number of HIV-1-infected patient cells employing reactive oxygen intermediate generators
EP0750039A1 (en) * 1995-06-20 1996-12-27 Boehringer Mannheim Gmbh Immunoregulatory protein LST-1
CA2224777C (en) * 1995-06-20 2010-08-03 Boehringer Mannheim Gmbh New immunoregulatory protein lst-1
TW201536278A (en) 2013-05-31 2015-10-01 Del Mar Pharmaceuticals Use of dianhydrogalactitol and analogs and derivatives thereof to treat recurrent malignant glioma or progressive secondary brain tumor

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1598811A (en) * 1977-01-12 1981-09-23 Hoffmann La Roche Carcinoma-associated antigens
US4725669A (en) * 1984-11-09 1988-02-16 President And Fellows Of Harvard College Assay for detecting infection by human T-cell lymphotropic virus-III

Also Published As

Publication number Publication date
EP0265516A1 (en) 1988-05-04
FI880020A0 (en) 1988-01-05
AU7434987A (en) 1987-12-01
WO1987006942A1 (en) 1987-11-19
US4785077A (en) 1988-11-15
FI880020A (en) 1988-01-05
ZA873212B (en) 1988-02-24
DK888A (en) 1988-03-01
JPH01500591A (en) 1989-03-01

Similar Documents

Publication Publication Date Title
DK330087A (en) SOLFILTER CONNECTION AND COMPOSITION CONTAINING SAME
NO872729D0 (en) CEPHALOSPORINHYDRATE AND PROCEDURE FOR ITS PREPARATION.
DK888D0 (en) PRACTICALLY TAKEN PURE HUMANT PROTEIN LYMPHOKIN AND ITS USE
NO861234L (en) PROCEDURE FOR EXTRACTION AND PURIFICATION OF PROTEINS.
NO863560L (en) DENTAL ARTICLES AND SILANOL BASIC SOLUTION FOR USE OF SUCH ARTICLES.
DK609689A (en) FOLIAMINATE AND ITS USE
DK122687A (en) POLYPEPTID, DNA AND USE THEREOF
DK551187D0 (en) THERAPEUTIC PREPARATION AND ITS PREPARATION
DK430683A (en) HUMANT IMMUNINTERFERON PROTEIN AND ITS PREPARATION AND USE
DK285388A (en) PEPTIME AND ITS USE
DK330187D0 (en) CHROMO-RELATED SOLFILTER COMPOUND AND COMPOSITION CONTAINING SAME
DK84588A (en) PHENYLGUANIDINE AND TETRAHYDROPYRIMIDE CONTAINING ANTHELMIC SUMMARY, ITS PREPARATION AND USE
DK127887D0 (en) INTERLEUKIN-1BETA DERIVATIVES AND MEDICINES CONTAINING SUCH DERIVATIVES
PT87554A (en) DIDINFECTING AND STERILIZING COMPOSITION
NO873216D0 (en) RECOMBINANT HTLV-III PROTEINS AND USE THEREOF.
DK381886A (en) MEDICAL PREPARATION AND PROCEDURE FOR ITS PREPARATION
NO864984D0 (en) WATERPROOF AND WATERPROOF POWERFUL MATERIALS AND GLOVES MANUFACTURED THEREOF.
DK413187A (en) SEMICARBAZONS AND THIOSEMICARBAZONS
DK69586A (en) POWDER-BITUMEN CONCENTRATE AND ITS APPLICATION
DK196088D0 (en) RECOMBINANT HTLV-III PROTEIN AND ITS USE
DK285288D0 (en) PEPTIME AND ITS USE
NO875220L (en) MALEIMIDES AND THERMO-HARD MIXTURES CONTAINING SUCH MALEIMIDES.
DK72186A (en) SOLVENT AND ITS APPLICATION
DK158286D0 (en) POWDER-BINDING CONCENTRATE AND ITS APPLICATION
DK363786A (en) HYDROQUINOLINES AND USE THEREOF

Legal Events

Date Code Title Description
AHB Application shelved due to non-payment